Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a disease mainly caused by the disorder of sex hormone metabolism in the elderly, which leads to the proliferation of glands and (or) fibers and muscle tissues to varying degrees, resulting in an increase in the size of the prostate, destruction of normal structure and a series of functional disorders. Benign prostatic hyperplasia is a common disease in middle-aged and elderly men, and about half of men over 50 years old will have clinical symptoms. The enlarged prostate squeezes the urethra, leading to a series of urination disorders, such as frequent urination, urgency, weak urine flow, and incomplete urination. These symptoms seriously affect the patient's quality of life. Failure to treat them in time can lead to many serious complications (such as acute urinary retention, stones, renal insufficiency, etc.), and may even endanger the patient's life.
-
Site of disease:
prostate -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Painful urination Urgency Frequent urination Acute urinary retention Incomplete bladder emptying -
Concurrent disease:
Related Drugs
TADALAFIL- tadalafil_tablet, film coated
Indication: Tadalafil 1. 4 Tadalafil tablets are indicated for the treatment of erectile dysfunction (ED). Tadalafil tablets are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Tadalafil tablets are indicated for the treatment of ED and the signs and symptoms of BPH (ED/BPH). If tadalafil is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks because the incremental benefit of tadalafil decreases from 4 weeks until 26 weeks, and the incremental benefit of tadalafil beyond 26 weeks is unknown [see Clinical Studies 14.
Manufacturer:
AvPAK
TAMSULOSIN HYDROCHLORIDE- tamsulosin hydrochloride_capsule
Indication: Tamsulosin hydrochloride capsules are an alpha 1 1 Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension ( 1 Tamsulosin hydrochloride capsules, USP are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies ( 14.
Manufacturer:
REMEDYREPACK INC.
TERAZOSIN- terazosin_capsule
Indication: Terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). There is a rapid response, with approximately 70% of patients experiencing an increase in urinary flow and improvement in symptoms of BPH when treated with terazosin. The long term effects of terazosin on the incidence of surgery, acute urinary obstruction or other complications of BPH are yet to be determined. Terazosin capsules are also indicated for the treatment of hypertension. They can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
Manufacturer:
REMEDYREPACK INC.